{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Real-World Outcomes Versus Clinical Trials for Mantle Cell Lymphoma

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Analyze data from two large, independent groups on the management of patients with mantle cell lymphoma (MCL).
  2. Explain the importance of exploring real-world differences in treatment patterns and outcomes for patients with MCL in academic and community settings.

Learning Outcomes

Seventy-five percent of participants will demonstrate knowledge of real-world data pertaining to the treatment of mantle cell lymphoma by achieving a minimum score of 70% on the outcomes-based posttest.
Price: $12.95

Credits:

  • ANCC 1.0 CH
  • DC - BON 1.0 CH
  • FL - BON 1.0 CH
  • GA - BON 1.0 CH
  • NM - BON 1.0 CH
  • SC - BON 1.0 CH
  • WV - BOERN 1.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.













Test Code: OT0922
Published: September 2022
Expires: 9/5/2025
Sources: Oncology Times
Required Passing Score: 8/10 (80%)
Authors: DIBASH KUMAR DAS, PhD